Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

23 jun 2013 8:30 a.m. - 27 jun 2013 12:45 p.m.

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Session Chair(s)

Mick  O'Quigley, MBA

Mick O'Quigley, MBA

Program Group Leader

Genentech, A Member of the Roche Group, United States

Learning Objective : Describe a portfolio oversight committee (sponsor/CRO) that improves alignment and delivers results; Explain how to build an integrated business unit across sponsor/CRO organizations; Describe how an investigative site network bridges communication between sponsor, CRO and sites.

Speaker(s)

Mick  O'Quigley, MBA

Strategies for Evolving a Sponsor/CRO Alliance to the Next Level: A Sponsor Perspective

Mick O'Quigley, MBA

Genentech, A Member of the Roche Group, United States

Program Group Leader

Michael  Henning, BSN, MBA

Strategies for Integrating a Sponsor/CRO Alliance into a CRO Business Model

Michael Henning, BSN, MBA

PPD, United States

Director, Project Management

Lisa  Marks

Panelist

Lisa Marks

PharmaSeek, United States

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.